| 1 |
Cai H, Lv M, Wang T. PANoptosis in cancer,the triangle of cel death [J]. Cancer Med, 2023, 12(24): 22206-22223.
|
| 2 |
Gao J, Xiong A, Liu J, et al. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment [J]. Cancer Gene Ther, 2024, 31(7): 970-983.
|
| 3 |
Ma W, Wang Q, Guo L, et al. The molecular mechanisms, roles, and potential applications of PANoptosis in cancer treatment [J]. Front Immunol, 2025, 16: 1550800.
|
| 4 |
Zhu P, Ke ZR, Chen JX, et al. Advances in mechanism and regulation of PANoptosis: prospects in disease treatment [J]. Front Immunol, 2023, 14: 1120034.
|
| 5 |
Bae H, Jang Y, Karki R, et al. Implications of inflammatory cell death-PANoptosis in health and disease [J]. Arch Pharm Res, 2024, 47(7): 617-631.
|
| 6 |
Liu X, Miao M, Sun J, et al. PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis [J]. Apoptosis, 2024, 29(3-4): 277-288.
|
| 7 |
Jin X, Zhu Y, Xing L, et al. PANoptosis: a potential target of atherosclerotic cardiovascular disease [J]. Apoptosis, 2025, 30(5-6): 1253-1271.
|
| 8 |
Tweedell RE, Hibler T, Kanneganti TD. Defining PANoptosis: biochemical and mechanistic evaluation of innate immune cell death activation [J]. Curr Protoc, 2024, 4(7): e1112.
|
| 9 |
Song K, Wu Y, Tan S. Caspases in PANoptosis [J]. Curr Res Transl Med, 2025, 73(1): 103502.
|
| 10 |
Qi Z, Zhu L, Wang K, et al. PANoptosis: Emerging mechanisms and disease implications [J]. Life Sci, 2023, 333: 122158.
|
| 11 |
Shi C, Cao P, Wang Y, et al. PANoptosis: a cell death characterized by pyroptosis, apoptosis, and necroptosis [J]. J Inflamm Res, 2023, 16: 1523-1532.
|
| 12 |
Zheng Y, Li J, Liu B, et al. Global trends in PANoptosis research: bibliometrics and knowledge graph analysis [J]. Apoptosis, 2024, 29(1-2): 229-242.
|
| 13 |
Wang L, Zhu Y, Zhang L, et al. Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases [J]. Cell Death Dis, 2023, 14(12): 851.
|
| 14 |
Ocansey DKW, Qian F, Cai P, et al. Current evidence and therapeutic implication of PANoptosis in cancer [J]. Theranostics, 2024, 14(2): 640-661.
|
| 15 |
Sun X, Yang Y, Meng X, et al. PANoptosis: mechanisms, biology, and role in disease [J]. Immunol Rev, 2024, 321(1): 246-262.
|
| 16 |
Pandeya A, Kanneganti TD. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes [J]. Trends Mol Med, 2024 , 30(1): 74-88.
|
| 17 |
Hou K, Pan W, Liu L, et al. Molecular mechanism of PANoptosis and programmed cell death in neurological diseases [J]. Neurobiol Dis, 2025, 209: 106907.
|
| 18 |
Műzes G, Sipos F. PANoptosis as a two-edged sword in colorectal cancer: a pathogenic mechanism and therapeutic opportunity [J]. Cells, 2025, 14(10): 730.
|
| 19 |
Fu H, Liu M, Li H, et al. Deciphering the prognostic landscape of esophageal adenocarcinoma: a PANoptosis-related gene signature [J]. J Cancer, 2025, 16(1): 183-200.
|
| 20 |
Cui Z, Li Y, Bi Y, et al. PANoptosis: a new era for anti-cancer strategies [J]. Life Sci, 2024, 359: 123241.
|
| 21 |
Yao M, Miao L, Wang X, et al. Targeting programmed cell death pathways in gastric cancer: a focus on pyroptosis, apoptosis, necroptosis and PANoptosis [J]. Gene, 2025, 960: 149546.
|
| 22 |
Zhao T, Zhang X, Liu X, et al. Characterizing PANoptosis gene signature in prognosis and chemosensitivity of colorectal cancer [J]. J Gastrointest Oncol, 2024, 15(5): 2129-2144.
|
| 23 |
Yu X, Shao Y, Dong H, et al. Biological function and potential application of PANoptosis-related genes in colorectal carcinogenesis [J]. Sci Rep, 2024, 14(1): 20672.
|
| 24 |
Wang Y, Zhao S, Du S, et al. Identification of PANoptosis associated lncRNAs associated with clinical prognosis and immune infiltration microenvironment in colon adenocarcinoma [J]. Discov Oncol, 2025, 16(1): 83.
|
| 25 |
Cai Y, Xiao H, Zhou Q, et al. Comprehensive analyses of PANoptosome with potential implications in cancer prognosis and immunotherapy [J]. Biochem Genet, 2025, 63(1): 331-353.
|
| 26 |
Chen S, Jiang J, Li T, et al. PANoptosis: mechanism and role in pulmonary diseases [J]. Int J Mol Sci, 2023, 24(20): 15343.
|
| 27 |
Li Y, Li J, Chen Y. PANoptosis-associated genes exhibit significant potential in the diagnosis of hepatocellular carcinoma [J]. J Gastrointest Oncol, 2025, 16(3): 1105-1114.
|
| 28 |
Sharma BR, Choudhury SM, Abdelaal HM, et al. Innate immune sensor NLRP3 drives PANoptosome formation and PANoptosis [J]. J Immunol, 2025, 214(6): 1236-1246.
|
| 29 |
Wang S, Luo M, Xu Q, et al. Discovery of TNI-97 as a highly selective, orally bioavailable HDAC6 inhibitor for the treatment of triple-negative breast cancer [J]. J Med Chem, 2025, 68(14): 14333-14356.
|
| 30 |
Cheng X, Zeng T, Xu Y, et al. The emerging role of PANoptosis in viral infections disease [J]. Cell Signal, 2025, 125: 111497.
|
| 31 |
Gao L, Shay C, Teng Y. Cell death shapes cancer immunity: spotlighting PANoptosis [J]. J Exp Clin Cancer Res, 2024, 43(1): 168.
|